Reference number : 236-2015-2016-Q2-00478, amendment number : , agreement type : G, recipient legal name : Uludag, Hasan, recipient country : CA, recipient province : AB, recipient city : Edmonton, recipient postal code : T6G 2E1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 597400.0, agreement start date : 2015-07-01, agreement end date : 2020-06-30, description english : siRNA Therapy for Leukemia: Synthetic Biomaterials to Deliver siRNA and Curb Uncontrolled Growth of Leukemic Cells, description french : siRNA Therapy for Leukemia: Synthetic Biomaterials to Deliver siRNA and Curb Uncontrolled Growth of Leukemic Cells, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2020-21), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2020-21), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada